Clinical Trials Sponsored by Institut de cancérologie Strasbourg Europe

Total 464 results

Institut de cancérologie Strasbourg Europe

Recruiting

Feasibility of an Advance Care Planning Intervention (PREVOIR)

Neoplasms

France
Institut de cancérologie Strasbourg Europe

Recruiting

Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) (ATICC)

Cervical Cancer

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma (SIB-DOPA)

Glioblastoma Multiforme, Adult
Institut de cancérologie Strasbourg Europe

Recruiting

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) (EPODIG-G)

Neoplasms | Digestive System Disease

France
Institut de cancérologie Strasbourg Europe

Recruiting

Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer (SIGHER)

HER2-positive Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation (MIFADORESOL)

Vaginal Cancer | Prostate Carcinoma | Radiotherapy | Rectum Carcinoma | Cervix Carcinoma | Anal Canal Carcinoma | Endometrium Carcinoma

France
Institut de cancérologie Strasbourg Europe

Completed

Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT) (RESPECT)

Hematologic Malignancy | Tumor, Solid

France
Institut de cancérologie Strasbourg Europe

Recruiting

Interest of Light Therapy in Hematology - The PHOTO-TREAT Study (PHOTO-TREAT)

Lymphoma | Leukemia, Myeloid, Acute

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Thero2-01S22 in HER2-positive Breast Cancer

HER2-positive Breast Cancer
Institut de cancérologie Strasbourg Europe

Recruiting

Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE) (EDIPE)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care (SNOEZELEN)

Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Deformable Image Registration for Breast Adaptive Tomotherapy (DIRB-ATOM)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients (PROTECT-05)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Hippotherapy Teenager-pediatric Radiotherapy (T-QAP)

Radiotherapy

France
Institut de cancérologie Strasbourg Europe

Recruiting

Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions (DERMOCOS)

Neoplasms

France
Institut de cancérologie Strasbourg Europe

Recruiting

Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma (TEPIREC)

Rectal Cancer

France
Institut de cancérologie Strasbourg Europe

Recruiting

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI (GlioCEST)

Glioma | Brain Metastases

France
Institut de cancérologie Strasbourg Europe

Recruiting

Platelet Transfusion Refractoriness (ACERTP)

Platelet Transfusion Refractoriness

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)

HER2-positive Breast Cancer
Institut de cancérologie Strasbourg Europe

Withdrawn

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) (HYACINTHE)

Hematologic Malignancy | COVID19

France
Institut de cancérologie Strasbourg Europe
Hôpitaux Universitaires de Strasbourg

Recruiting

Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM) (OPPIDOM)

Squamous Cell Carcinoma of Head and Neck | Oropharyngeal Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma

France
Institut de cancérologie Strasbourg Europe
LEAF4Life, Inc.

Completed

A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes

Acute Respiratory Distress Syndrome | COVID19, Sepsis or Other Causes

France
Institut de cancérologie Strasbourg Europe
ICube Laboratory

Completed

Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI. (ATLATEP)

Brain Diseases

France
Institut de cancérologie Strasbourg Europe
UR 3072

Recruiting

Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer (PROTECT-COEUR)

Breast Cancer

France
French Innovative Leukemia Organisation
Institut de cancérologie Strasbourg Europe

Completed

Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 (COVID19_LLC-MW)

Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease

France
Institut de cancérologie Strasbourg Europe
Centre Georges Francois Leclerc

Not yet recruiting

Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study (ReciDOPA)

Glioblastoma

France
Institut de cancérologie Strasbourg Europe
Hôpitaux Universitaires de Strasbourg; GENTYANE (GEnoTYpage and sequencing...

Completed

Optical Genome Mapping in Characterization of Multiple Myeloma (MYELOPTIC)

Multiple Myeloma

France
Institut de cancérologie Strasbourg Europe
Ministry of Health, France; National Cancer Institute, France

Not yet recruiting

Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR) (IMCOR)

Renal Carcinoma

France
Institut de cancérologie Strasbourg Europe
Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Recruiting

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer (TNBC-RT2023)

Triple-negative Breast Cancer

France
Institut de cancérologie Strasbourg Europe
Université de Strasbourg - Unité de Recherche 3072 - Mitochondries, Stress...

Completed

Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study (PROTECT-06)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe
UR 3072 - Mitochondries, Stress oxydant, Protection musculaire

Completed

Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients (PROTECT-03)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe
UR 3072 - Mitochondrie, Stress oxydant et Protection musculaire

Completed

Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04) (PROTECT-04)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe
Continuum Plus Santé; Plateforme nationale qualité de vie et cancer; WeShare

Recruiting

Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution (FEGALA)

Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Colorectal Neoplasms

France
Institut de Cancérologie de Lorraine

Recruiting

Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted. (PROTOTOX)

Quality of Life | Cancer | Hearing Disorders | Ototoxicity, Drug-Induced

France
Institut de Cancérologie de Lorraine

Not yet recruiting

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) (EFACog)

No Metastatic Breast Cancer

France
Institut de Cancérologie de Lorraine

Recruiting

Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia (PhotodiVIN)

Vulvar Intraepithelial Neoplasia | Vulvar High Grade Squamous Intraepithelial Lesion | Differentiated Vulvar Intraepithelial Neoplasia

France
Institut de Cancérologie de Lorraine

Recruiting

Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) (PERCIMEL)

Melanoma

France
Institut de Cancérologie de Lorraine

Recruiting

Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC (PIPADN)

Peritoneal Carcinomatosis

France
Institut de Cancérologie de Lorraine

Completed

Unusual Toxicity Induced by Radiotherapy (CRYOTOX)

Cancer

France
Institut de Cancérologie de Lorraine

Completed

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure (ANIBPV)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch (ENHYZA)

Pain

France
Institut de Cancérologie de Lorraine

Completed

Mastectomy in Ambulatory Breast Surgery (MASTAMBU)

Mastectomy

France
Institut de Cancérologie de Lorraine

Completed

Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area (SALVADS-Fluo)

Head and Neck Cancer

France
Institut de Cancérologie de Lorraine

Completed

Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection (CyPaM2)

Bladder Cancer

France
Institut de Cancérologie de Lorraine

Completed

Place of General Medical During Oncology Care Management (MGPEC_Onco)

Oncologic Disorders

France
Institut de Cancérologie de Lorraine

Completed

RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer (SPLICI-Rad)

Fibrosis | Breast Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma (HACAMI)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Feasibility Study of Supine Breast MRI : Comparison With Prone MRI and Comfort Assessment

Breast Diseases
Institut de Cancérologie de Lorraine

Completed

A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas

Sarcoma,Soft Tissue
Institut de Cancérologie de Lorraine

Completed

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

Brain Metastasis

France

3

Subscribe